Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Industry Valuation for the Precision Genomic Testing Sector?

The market size of precision genomic testing has witnessed a swift expansion in the past few years. There is a forecasted growth of this market from $13.44 billion in 2024 to $15.00 billion in 2025, reflecting a compound annual growth rate (CAGR) of 11.6%. The notable expansion during the historic period can be credited to various factors. A few of them include the growing accessibility to direct-to-consumer genetic tests, enhanced partnerships between pharmaceutical and diagnostic companies, the burgeoning emphasis on preventative healthcare, the rise in the use of companion diagnostics, and increased awareness about early detection of diseases.

The market for precision genomic testing is anticipated to experience swift expansion in the coming years, reaching a value of $23.11 billion by 2029, with an annual growth rate of 11.4%. This growth during the forecast period is due to an increase in demand for precision oncology solutions, heightened attention on rare disease diagnostics, a rise in investment in population genomics initiatives, an increased use of multi-omics methods, and a surge in demand for non-invasive prenatal testing. Some key trends anticipated during this forecast period include advancements in next-generation sequencing technologies, innovations in liquid biopsy techniques, the application of artificial intelligence in genomic analysis, improvements in the interpretation of multi-omics data, and new developments in direct-to-consumer genetic testing models.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25883&type=smp

What Forces Are Driving The Growth Of The Precision Genomic Testing Market?

The increase in genetic disorders is set to fuel the expansion of the precision genomic testing market. Medical conditions resulting from anomalies in a person’s DNA, such as single or multiple gene mutations or changes in chromosome structure or quantity, are known as genetic disorders. The mounting prevalence of genetic disorders can primarily be attributed to the rise in maternal age, as older mothers are more likely to pass on chromosomal abnormalities like down syndrome to their offspring. Precision genomic testing facilitates the prompt detection and precise diagnosis of genetic disorders by isolating specific gene mutations, paving the way for individualized interventions and treatment plans. For example, in May 2025, Gene People, a UK-based registered charity, reported that approximately 1 in 25 children are affected by genetic conditions, affecting over 2.4 million children and adults in the UK. Furthermore, a genetic condition is diagnosed in roughly 30,000 newborns and children in the UK annually. Consequently, the growing prevalence of genetic disorders is boosting the precision genomic testing market’s growth.

How Is The Precision Genomic Testing Industry Segmented Across Key Parameters?

The precision genomic testing market covered in this report is segmented –

1) By Product And Service: Consumables, Equipment, Services

2) By Technology: Next-Generation Sequencing, Polymerase Chain Reaction, Microarray Technology, Sanger Sequencing, Clustered Regularly Interspaced Short Palindromic Repeats Or Clustered Regularly Interspaced Short Palindromic Repeats-Associated Systems, Other Technologies

3) By Application: Oncology, Cardiovascular Diseases, Neurological Disorders, Reproductive Health, Rare Diseases, Other Applications

4) By End-Users: Hospitals And Clinics, Diagnostic Laboratories, Research And Academic Institutes, Other End-Users

Subsegments:

1) By Consumables: Reagents And Kits, Deoxyribonucleic Acid Or Ribonucleic Acid Extraction Kits, Library Preparation Kits, Sequencing Reagents, Polymerase Chain Reaction Assay Kits, Buffers And Enzymes

2) By Equipment: Next-Generation Sequencing Systems, Polymerase Chain Reaction Machines, Microarray Instruments, Deoxyribonucleic Acid Analyzers, Bioinformatics Workstations, Laboratory Automation Systems

3) By Services: Genomic Data Analysis Services, Laboratory Testing Services, Genetic Counseling Services, Clinical Interpretation Services, Contract Research Services, Custom Assay Development Services

Which Trends Are Redefining The Future Landscape Of The Precision Genomic Testing Industry?

Leading firms in the precision genomic testing market are aiming to offer innovative solutions, such as ultra-sensitive circulating tumor deoxyribonucleic acid assays for more accurate and earlier detection of cancer. These advanced assays can identify tiny fragments of deoxyribonucleic acid derived from tumors in the blood, facilitating the early and accurate identification of cancerous genetic mutations. For example, in April 2025, Natera Inc., a clinical genetic testing enterprise headquartered in the US, introduced the ultra-sensitive Signatera genome molecular residual disease test. By using whole genome sequencing of a patient’s tumor and matched normal deoxyribonucleic acid, this test creates a tailored assay capable of identifying circulating tumor deoxyribonucleic acid to as small as 1 part per million. This significant sensitivity enables early and precise identification of recurring cancer, thereby improving treatment planning and patient supervision across varying cancer types.

Which Companies Currently Dominate The Competitive Landscape In The Precision Genomic Testing Industry?

Major companies operating in the precision genomic testing market are Roche Diagnostics International AG, Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Illumina Inc., Revvity Inc., QIAGEN N.V., Exact Sciences Corporation, Natera Inc., Myriad Genetics Inc., GenScript Biotech Corporation, Fulgent Genetics Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., Ambry Genetics Corporation, Color Health Inc., Pacific Biosciences, Eurofins Genomics LLC, Precision Genetics.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/precision-genomic-testing-global-market-report

Which Geographic Regions Are Driving Demand In The Precision Genomic Testing Market?

North America was the largest region in the precision genomic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision genomic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=25883&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model